PErsonalized TReatment for Endometrial Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Endometrial Adenocarcinoma
Interventions
OTHER

Comparison of chemotherapy vs. chemoradiotherapy

"Chemotherapy (paclitaxel-carboplatin) vs. chemoradiotherapy (paclitaxel-carboplatin followed by whole pelvic radiotherapy)~Patients assigned to chemotherapy receive paclitaxel (175 mg/m2) and carboplatin (area under curve, 5) every 3 weeks for 6 cycles. The pelvic radiotherapy dose is 45 to 50.4 Gy over 5 to 6 weeks (1.8 Gy per day for 25 to 28 fractions)."

OTHER

Comparison of VBT vs. WPRT

"Vaginal brachytherapy vs. whole pelvic radiotherapy~Patients randomized to vaginal brachytherapy receive cuff brachytherapy at 21 Gy in 3 fractions of 7 Gy at 0.5 cm depth. The pelvic radiotherapy dose is 45 to 50.4 Gy over 5 to 6 weeks (1.8 Gy per day for 25 to 28 fractions)."

Trial Locations (1)

00290

RECRUITING

Helsinki University Hospital, Helsinki

All Listed Sponsors
collaborator

Turku University Hospital

OTHER_GOV

collaborator

Tampere University Hospital

OTHER

collaborator

Kuopio University Hospital

OTHER

collaborator

Oulu University Hospital

OTHER

collaborator

Kymenlaakso Central Hospital Kotka Finland

OTHER

collaborator

Päijänne Tavastia Central Hospital

OTHER

collaborator

South Carelia Central Hospital

OTHER

lead

University of Helsinki

OTHER